Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.

We evaluated the safety and immunogenicity of attenuated Shigella flexneri 2a vaccine candidate CVD 1203, which harbors precise deletions in the plasmid gene virG and in the chromosomal gene aroA. CVD 1203 invades epithelial cells but undergoes minimal intracellular proliferation and cell-to-cell sp...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Yayımlandı:	Infect Immun
Asıl Yazarlar:	Kotloff, K L, Noriega, F, Losonsky, G A, Sztein, M B, Wasserman, S S, Nataro, J P, Levine, M M
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Microbiology (ASM) 1996
Konular:	Research Article
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174410/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8890204/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.64.11.4542-4548.1996
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.

Benzer Materyaller